Yale University

University / College


Location: New Haven, CT, United States (USA) (US) US

ISNI: 0000000419368710

ROR: https://ror.org/03v76x132

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fast Quantum Control of Cavities Using an Improved Protocol without Coherent Errors (2024) Landgraf J, Flühmann C, Fösel T, Marquardt F, Schoelkopf RJ Journal article Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor (2024) Brösecke F, Pfau A, Ermer T, Dein Terra Mota Ribeiro AB, Rubenbauer L, Rao VS, Burlein S, et al. Journal article Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (2024) Schmid P, Cortes J, Dent R, Mcarthur H, Pusztai L, Kümmel S, Denkert C, et al. Journal article Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer (2024) Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber KE, Rachakonda S, et al. Journal article Multimodal assessment of brain stiffness variation in healthy subjects using magnetic resonance elastography and ultrasound time-harmonic elastography (2024) Klemmer Chandía S, Schattenfroh J, Brinker ST, Tzschaetzsch H, Sack I, Meyer T Journal article Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy (2024) Gudera JA, Baehring JM, Karschnia P Journal article Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article EANS Epilepsy surgery Brain Dissection Course Vienna 2024 (2024) Rössler K, Van Roost D, Schijns O, Ackermans L, Delev D, Batista PD, Erőss L, et al. Journal article A brave new framework for glioma drug development (2024) Hotchkiss KM, Karschnia P, Schreck KC, Geurts M, Cloughesy TF, Huse J, Duke ES, et al. Journal article, Review article Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: Quality-of-life results from the randomized KEYNOTE-522 study (2024) Dent R, Cortés J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, et al. Journal article